Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

A distal pancreatectomy is the removal of the end of the pancreas while leaving the pancreatic head attached. It is performed to treat pancreatic cancer localized in the end of the pancreas, but may ...

Silexion Therapeutics Corp. announced promising results from preclinical studies of its RNA interference therapy, SIL204, for KRAS-driven pancreatic cancer. The research, conducted in orthotopic ...

(RTTNews) - Silexion Therapeutics (SLXN) announced positive data from preclinical studies of SIL204, its RNA interference (RNAi) therapy, in orthotopic pancreatic cancer models. These findings ...